Efavirenz
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4739 publications
AI-MedCraft: A Strategy-Driven AI Platform for Multi-Objective Molecular Design.
Journal: Journal of chemical information and modeling
Published: March 27, 2026
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya.
Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026
Drug Resistance in HIV Following First-line ART Failure: Insights from a Cross-sectional Study in India.
Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026
Changes in Metabolic Parameters After Switching From Efavirenz to Dolutegravir-Based Regimen: A Cohort Study in Thai People Living With HIV.
Journal: Journal of the International Association of Providers of AIDS Care
Published: March 10, 2026
Longitudinal analysis of viral suppression before, during, and after pregnancy among women on antiretroviral therapy in Uganda: six-year real-world experience.
Journal: HIV research & clinical practice
Published: February 28, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.
Journal: The Pediatric infectious disease journal
Published: February 24, 2026
Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 13, 2026
Distinct biochemical phenotypes of HIV exposed infants driven by antiviral medication.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
Effectiveness and safety of ainuovirine plus lamivudine and tenofovir DF in virologically suppressed people living with HIV-1: the 48-week results of a multicenter, real-world study.
Journal: Antimicrobial agents and chemotherapy
Published: February 03, 2026
Efficacy and safety of bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF) versus efavirenz, lamivudine, and tenofovir disoproxil fumarate (EFV+3TC + TDF) in late-presenting people with HIV rapid initial antiretroviral therapy.
Journal: BMC infectious diseases
Published: December 24, 2025
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 18, 2025
Last Updated: 04/28/2026